Aluminum

Aluminum toxicity is a serious condition that occurs when a person absorbs excessive amounts of aluminum—a metal that often deposits itself in the brain. Aluminum is the most abundant metallic element in the earth’s crust and is introduced into the body through the digestive system, lungs and skin, before it is absorbed into the tissues.

The highest exposure to aluminum is most frequently due to chronic consumption of aluminum-containing antacid products. Research shows that aluminum builds up in the body over time, creating an increased health hazard as people get older.

Aluminum toxicity can lead to symptoms similar to Alzheimer’s disease and osteoporosis and can impair kidney function. Aluminum toxicity can also lead to colic, rickets, gastrointestinal problems, poor calcium metabolism, anemia, headaches and decreased liver function. A disturbing pattern of aluminum accumulation and interference with normal neurological function appears to be supported in many scientific arenas.

Recent studies suggest that aluminum contributes to neurological disorders such as Alzheimer’s disease, Parkinson’s disease, senile and pre-senile dementia, clumsiness of movements, staggering when walking, and the inability to pronounce words properly. Autopsies, performed on people who have died of Alzheimer’s disease, showed accumulations of up to four times the normal amount of aluminum in the nerve cells of the brain. Levels were especially high in the hippocampus, which plays a central role in memory.

There are also geographical links between Alzheimer’s disease and high aluminum in drinking water. Elevated hair aluminum has been observed in Alzheimer’s patients. Amyotrophic lateral sclerosis, another neurodegenerative disease, may also be linked to aluminum content of water supplies. Behavioral difficulties among schoolchildren have also been associated with elevated levels of aluminum and other neurotoxic heavy metals. Studies show that dyslexic children have higher levels of aluminum in their hair, when compared with controls.

Chemical & Heavy Metal Cleanse Starter Kit $149.85 [ learn more ] The Chemical & Heavy Metal Starter Kit was designed by Dr. Group for individuals that are new to the cleansing process, or are simply looking for an easy-to-perform, cost effective cleanse program. The Heavy Metal Starter Kit is comprised of LIFE Detox Foot Patches™, NDF Plus™, and Quantum Zeolite™.

Cadmium

Cadmium is a widespread heavy metal in the environment and in our bodies. It is very poisonous, and we only excrete cadmium in very small amounts.

Cadmium can cause damage to all types of body cells. By damaging the cell membrane, cadmium increases the permeability of the cells, one of the consequences being that the transfer of other heavy metals into the cells is facilitated. In the acute stage, cadmium intoxication causes enteritis. A slow accumulation of cadmium takes place, mainly in the kidneys; the liver and bones are other important sites for cadmium storage.

Food products account for more than 90 percent of human exposure to cadmium, except in the vicinity of cadmium-emitting industries, according to the Agency for Toxic Substances and Disease Registry. Cadmium has fast uptake through the roots to edible leaves, fruits and seeds. Cadmium builds up in animal milk and fatty tissues. A 1990 study showed that acute cadmium toxicity from food is rare, but chronic exposure at lower levels increases cadmium in certain body organs.

One source of cadmium in our environment, and main reason for cadmium accumulating in the body, is tobacco smoke. One cigarette contains 16-24 mcg. of cadmium of which the body absorbs approximately half. In addition to this, 5 - 10% of the cadmium from our food and other sources is absorbed; therefore, a substantial amount of cadmium is stored in our body system over a number of years.

Prolonged accumulation of cadmium in the body stains the teeth. It can cause damage to the nervous system, decrease the detoxification power of the organism, it can cause high blood pressure and atherosclerosis, damage the immune system; most importantly the antibody production, decrease fertility, cause anemia, emphysema, and cancer.

Increased concentrations of cadmium had been found in the placenta of women who have given birth to children with low birth weight, neural damage, and Down’s syndrome. Children who are exposed to large concentrations of cadmium in their environment often have learning disabilities.

Chemical & Heavy Metal Cleanse Starter Kit $149.85 [ learn more ] The Chemical & Heavy Metal Starter Kit was designed by Dr. Group for individuals that are new to the cleansing process, or are simply looking for an easy-to-perform, cost effective cleanse program. The Heavy Metal Starter Kit is comprised of LIFE Detox Foot Patches™, NDF Plus™, and Quantum Zeolite™.

Arsenic

Arsenic diagnosis, especially from low doses of inorganic arsenic (the type found in Chromated Copper Arsenate or CCA-treated lumber) is not easy. According to the EPA, CCA is a highly toxic chemical formulation that contains water, arsenic acid, chromic acid, and copper oxide, and is primarily used as a wood preservative and insecticide/fungicide.

It is found virtually everywhere. It is sold in lumber and hardware stores nationwide and is used by consumers and contractors to construct decks, playgrounds and fences. There is no one set of symptoms; responses vary, depending upon exposure means and levels.

Arsenic can be inhaled, ingested (swallowed) or absorbed through contact. Arsenic poisoning is difficult to pin down; most of the arsenic leaves the body within three days of exposure.

The arsenic that remains is stored in the brain, bones, and tissue and continues to do serious damage. Some people have no immediate symptoms but the exposure can cause diabetes and many types of cancer later on.

There is new evidence that arsenic may also lead to heart disease and strokes. It may cause long term liver, kidney, and central nervous system damage.

Arsenic exposure, even at low levels, can result in a range of symptoms. Swallowing or inhaling low levels of inorganic arsenic can result in stomach ache, nausea, vomiting and diarrhea.

It can also result in decreased production of red and white blood cells, which may cause fatigue, abnormal heart rhythm, blood-vessel damage (resulting in bruising), and impaired nerve function. One of the early warning signs of arsenic poisoning is a “pins and needles” sensation in the hands and feet.

Long-term oral exposure to inorganic arsenic can result in skin changes including a darkening of the skin and the appearance of small “corns” or “warts” on the palms, soles, and torso.

Other signs and symptoms include skin thickening, fluid accumulation (resulting in puffiness) especially around the lower eyelids, face and ankles, diarrhea, garlic breath, perspiration, excessive salivation, generalized itching, oral inflammation, sore throat, runny nose, excessive tearing, numbness, skin inflammation, hair loss, weakness, and loss of appetite.

Arsenic can also cause a range of neurological effects, including headaches and vision problems. It can cause noticeable behavioral changes, most commonly aggression or depression.

Lead

Lead is practically everywhere in today’s environment. It enters our bodies from many sources. Lead poisoning victims usually become anemic. Their symptoms usually persist for about two weeks from time of exposure, and then settle into the organs, bones & even hair. We still do not know the long-term effects of lead exposure.

Lead poisoning symptoms are commonly overlooked by doctors and are not properly diagnosed as lead poisoning, since they are vague.

Dr. Claire Patterson of the California Institute of Technology did a study in 1965 called “Contaminated and Natural Lead Environments of Man,” which offered first hand proof that high lead levels in industrial nations are man-made and endemic. In fact, the study showed that the average bone lead level of a deceased person today averages approximately 1000 times higher than that of deceased people who lived 400-500 years ago.

After phasing out lead in gasoline, reducing lead levels in food should be our greatest health priority. Lead intake from fresh vegetables and fruits can be reduced by thorough washing and by peeling root vegetables. Food produced close to heavy traffic or lead-emitting industries will have more lead. Fertilizers with sewage sludge added to them may boost soil lead levels — check with the supplier. Lead in processed foods is picked up at various stages from growing to packaging.

There are estimates that 13 to 22 per cent of our dietary lead intake is from lead-soldered food cans. Unfortunately, the U.S. does not regulate and test for lead in all canned foods. Food in cans with lead-soldered seams can be dangerous; particularly cans that contain acidic substances such as fruit juices and some vegetables. Imported canned goods are more likely to have soldered seams. Cans with round bottoms (extruded cans) are safe and do not have a seam or use lead.

Mercury

Mercury is one of the most toxic elements on the planet, probably second only to plutonium, yet (worldwide) people have it in all tissues of their bodies. It continues to be dumped into our waterways and soil, placed into our teeth, and injected into our bodies through vaccinations.

Toxicity caused by excessive mercury exposure is now becoming recognized as a widespread environmental problem and is continuing to attract a great deal of public attention.

A National Academy of Sciences study published in July 2001 estimates that up to 60,000 children born in the USA each year may be affected by mercury toxicity. In March of 2002, an environmental group had charged the FDA of failing to warn the public of the dangers of mercury contamination from eating tuna, which contains high levels of mercury.

Texas researchers have found a possible link between autism and mercury in the air and water. In fact, the incidence of autism has grown in the past 20 years, from one in every 2,000 children to as high as one in every 166! Researchers have been hard-pressed to explain the increase, but many believe mercury to be the culprit.

The World Health Organization (WHO) reports that the amount of mercury absorbed daily by the average human body is 0.3 micrograms (mcg) from water and air, 2.61 mcg from fish, and 17 mcg from dental amalgams (silver fillings). Research points out that 80% of mercury vapor is absorbed into the blood, going directly from the nose to the brain, following nasal nerve pathways. Dentists have four times as much of a body burden of mercury as an average non-dentist.

Dental workers show 50-300% more mercury in hair and fingernails than the average population. Before public awareness campaigns started, it is a notable fact that the preservative thiomerasol (usually added to vaccines) contained mercury. In 1999, the CDC called for the removal of mercury from vaccines. Paradoxically, the CDC still continues to recommend the measles, mumps and rubella vaccine.

If you are one of the millions of Americans who has received silver dental fillings, take notice. Mercury makes up about 50 percent of every amalgam dental filling, also known as “silver” fillings. Amalgam fillings can release mercury for up to 70 years. Someone with eight amalgams, for example, could have 120 mcg released into the saliva per day.

The maximum allowable by the EPA is less than 0.1 mcg per kilogram of body weight per day, to be absorbed into the human body. We now know that the dental mercury/silver amalgam filling is “chemically & electrically active.” Science has proven that every time we eat, drink, or breathe, we may be absorbing disturbing releases of decomposing, toxic particles—mercury included. This chronic, toxic accumulation is being shown to have serious, long-term consequences on our immune system, resulting in a variety of disease and conditions.

Consider that while 78% of Americans have dental fillings, 95% of people with disorders of the central nervous system such as MS, epilepsy, paralysis and migraines also have silver dental fillings. This begs the question: Would you want mercury—one of the most powerful neurotoxins on the planet—embedded in your mouth, only inches from your brain?

The answer is obvious. This is the same reason why you can no longer buy an oral or rectal mercury thermometer.

Toxic Heavy Metals

We have been exposed to heavy metal toxins for an immeasurable amount of time. The industrialization of our planet has drastically increased the environmental burden of heavy metal toxins, to the point that we are dependent upon them for proper functioning.

Industry and commercial processes are actively mining, refining, manufacturing, burning, and manipulating heavy metal compounds for many reasons. Presently, heavy metals are abundant in our drinking water, air and soil due to our increased use of these compounds. They are present in virtually every area of modern consumerism.

Toxic metals are found in construction materials, cosmetics, medicines, processed foods, fuel sources, appliances, personal care products and so much more. It is very difficult, if not impossible, for anyone to avoid exposure to any of the many harmful toxic heavy metals that are so ubiquitous in our environment. It doesn’t look like we will successfully neutralize the threat of heavy metal toxicity in our communities, nor diminish our use of the many commercial goods that they help produce. We can, however, take steps to understand and deal with this threat. Cadmium, aluminum, mercury, antimony, lead and arsenic are some of the heavy metals added to our food chain from upstream industrial discharges, pesticide runoff, incinerator emissions, and smokestacks, as well as aviation.

Heavy metals are found in the air we breathe, from factories, automobiles and in places you wouldn’t imagine. Low-level metal toxicity is recognized by the Environmental Protection Agency (EPA), the Food & Drug Administration (FDA), and the Centers for Disease Control (CDC), as well as by individual state health departments.

The American Heart Association states that blood-levels of lead and cadmium may increase the risk of peripheral artery disease — even at levels currently considered safe. Low-level toxicity from heavy metals and the resulting “oxidative stress” are associated with a depressed immune system, increases in infertility, cancer, cardiovascular disease, and premature mortality.

Emerging evidence shows that blood and bone lead levels, reflecting relatively modest exposures, are also associated with hypertension, renal insufficiency, and cognitive impairment. Studies conducted at the National Academy of Science (NAS) show clear and present danger of heavy metals in our bodies. Tuna, dental fillings and vaccinations containing mercury, can cause problems including birth defects, brain damage, depression, fatigue, hearing loss, vision loss, kidney damage and many more ailments.

The really bad news is that, according to the EPA, 99% of our population contains chemicals that are linked to the development of cancer. Most heavy metals are carcinogenic and can cause free radical damage. They can cause the energy factories in our cells (known as mitochondria) to stop working, which essentially causes cells to die. In the process, the DNA for those affected cells may also be damaged, causing a malfunction in the next generation of cells of this type.

When cells are programmed to die off more quickly or to wildly multiply, we see problems such as weaker tissue, maligned function, or tumors. In short, heavy metals lead to serious illnesses and shorten our lives. There are more than twenty different heavy-metal (environmental) toxins that can impact human health—each toxin producing unique behavioral, physiological, and cognitive changes in an exposed individual.

The degree to which a system, organ, tissue, or cell is affected by a heavy metal toxin depends on the toxin itself and the degree of the individual’s exposure. Here we examine just five of the many hazardous heavy metals that we are commonly exposed to.

Chemical & Heavy Metal Cleanse Starter Kit $149.85 [ learn more ] The Chemical & Heavy Metal Starter Kit was designed by Dr. Group for individuals that are new to the cleansing process, or are simply looking for an easy-to-perform, cost effective cleanse program. The Heavy Metal Starter Kit is comprised of LIFE Detox Foot Patches™, NDF Plus™, and Quantum Zeolite™.

Environmental toxins are everywhere

Our industrialized society has left a toxic footprint in our air, water, food, soil and, unfortunately, our bodies. In fact, there is no safe place left. As you are about to discover, these harmful toxic metals and chemicals enter our body every day of our lives.

Once these toxic chemicals absorb into our bodies, they spread through our entire system where they get locked into our chemistry and start to create disease. The problem is that toxins are not meant to be metabolized or broken down by our bodies, so they start to stockpile, slowly building up.

These environmental poisons overwhelm our ability to detoxify them, eventually causing disease. We don’t get cancer, heart disease, diabetes or any one of the other degenerative diseases overnight—we spend our whole lives saving up for them.

Cornea: Our Vision May Change within the Blink of an Eye

A study found that the upper eyelid's pressure and shape of its opening work to change the shape of our eyes throughout the day.


Eyelids do a whole lot more than hold up our eyelashes and keep the sun out, Scott Read, a Queensland University of Technology PhD optometry researcher, has found. He stated that the biggest changes were amongst people who maintained a downward gaze for a long time while reading or doing close work. "The first study found that there were highly significant changes to the contours of the cornea throughout the day when we tested at 9am, 1pm and 5pm over three days of the week," Read said. "The study found horizontal bands of distortion appeared on the cornea where the eyelid would have been sitting and that this increased during the day but went back to normal by the next morning.”

"As these changes appear to be related to forces from the eyelids themselves and were more marked in people who spent a lot of time reading in downward gaze it is certainly one reason why people's vision may be slightly worse at the end of the day or after doing a lot of close work,” he stated. “It suggests that people should take a short break from reading or close work at least every hour." I

n a second study on 100 normal-sighted young subjects, Read described the shape of the eyelid opening at different angles of gaze and compared this with the contours of the cornea to find out how eyelid characteristics and corneal shape affected each other. He found significant associations between the angle, shape and size of the eyelids and the shape of the cornea. "It appears eyelids do play a part in determining the shape of the cornea. One explanation is that pressure from the eyelids is involved in the cause of corneal astigmatism.

His findings would provide the groundwork for new understanding about astigmatism in children and in older age. "Children are born with a high degree of astigmatism and the cornea changes shape rapidly in the first four years of life, so the study's findings could shed light on how some people go on to develop astigmatism," he said.

MEDICA.de; Source: Queensland University of Technology

Transplantation: Hepatitis C Associated With Decreased Survival

Heart transplant patients who receive a donor heart from a person with hepatitis C have a lower rate of survival, according to a study.

A shortage of cardiac organ donors results in a substantial number of deaths among persons awaiting cardiac transplantation. One potential approach for increasing the availability of donors is to broaden the criteria used to identify appropriate donors. For example, the cardiac donor pool could be expanded by using donors with hepatitis C virus (HCV) infection.

Hearts from donors infected with HCV carry a substantial risk of transmission of HCV to the recipient, and high rates of subsequent liver enzyme abnormalities have been observed, according to background information in the article. The effect on patient survival has not been clear. Leanne B. Gasink, M.D., M.S.C.E., of the University of Pennsylvania School of Medicine, Philadelphia, and colleagues conducted a study to determine the relationship between donor HCV status and survival in cardiac transplant recipients.

The study included data from the Scientific Registry of Transplant Recipients. Adult heart transplant patients who received their transplants between April 1994 and July 2003 were eligible for inclusion. Of 10,915 patients meeting entry criteria, 261 received an HCV-positive donor heart.

The researchers found that the rate of death was higher among recipients of hearts from HCV-positive donors compared with recipients of hearts from HCV-negative donors at 1 year (16.9 percent vs. 8.2 percent), 5 years (41.8 percent vs. 18.5 percent), and 10 years (50.6 percent vs. 24.3 percent). At 1, 5, and 10 years, survival rates were 83 percent, 53 percent, and 25 percent for recipients of HCV-positive donor hearts, and 92 percent, 77 percent, and 53 percent for recipients of HCV-negative donor hearts, respectively.

This association appears to be independent of recipient HCV status and age. Recipients of HCV-positive donor hearts were more likely to die of liver disease and coronary vasculopathy (disease of the coronary arteries).

MEDICA.de; Source: American Medical Association

Killing Brain Tumours: A “Trojan Horse” Approach

A new method for targeting malignant brain tumours through inducing the cancerous cells to “commit suicide” has been developed by a team of researchers headed by a Hebrew University of Jerusalem professor of biochemistry.

Alexander Levitzki, who is the Wolfson Family Professor of Biochemistry, his research associate, Dr. Alexei Shir, and his colleagues from the Ludwig-Maximilians University of Munich, Germany, have pioneered a technique in which a molecule containing long, double-stranded RNA is attached to epidermal growth factor (EGF) and delivered selectively to cells with an abnormally high number of epidermal growth factor receptors (EGFR).

This proliferation of EGFR is typical of certain types of cancer cells, including glioblastoma multiforme (GBM), the most lethal form of brain cancer. The nucleic acid-EFG molecule acts as a “guided missile,” explained Levitzki, which, when injected into the blood stream, is avidly gobbled up by the multiple EGF receptors on the cancer cells, without harming normal cells. Once embedded in the tumour cells, it destroys them from within – a true “Trojan horse,” said Levitzki.

Normal cells, which possess 20 to 100 less receptors for EGF, would be spared, since the amount of double-stranded RNA gobbled up is insufficient to induce them to die. The lethal RNA approach has been applied to mice in which human brain tumours were grown. The tests proved 100% effective in eliminating the tumourous growths. Further testing is planned in a clinical setting.

In the meantime, a small start-up company has been established to promote commercial development of the new drug. Levitzki believes that the project has great potential, especially in view of the fact that over-expression of EGF receptors is involved in over 25 % of all types of cancers. The strategy developed to combat GBM can also be applied to other types of receptors found on cancerous cells, he added.

MEDICA.de; Source: Hebrew University of Jerusalem

Drinks: Alcohol Lowers Heart Attack Risk

A study shows: Among men with healthy lifestyles, those who consume moderate amounts of alcohol have a 40 to 60 percent reduced risk of heart attack compared with healthy men who don´t drink at all.

"This latest research speaks to how robust the link is between moderate drinking and heart attack risk," explains lead author Kenneth Mukamal, MD, MPH, Associate Professor of Medicine at Harvard Medical School. " Studies have consistently found an association between moderate alcohol consumption and reduced heart attack risk in men.

But up to now they could not answer the question if the men who drank in moderation were the same individuals who maintained good eating habits, didn't smoke, exercised and watched their weight and if their reduced risk of myocardial infarction wasn't the result of one or more of these other healthy habits.

The members of the group that was studied, reported four healthy lifestyle behaviours: body mass index (BMI) of less than 25; moderate to vigorous physical activity for at least 30 minutes per day; abstention from smoking; and a healthy diet. Over a follow-up period of 16 years, the authors assessed the participants' daily alcohol intake (beer, white wine, red wine, or spirits) using a standardized and validated questionnaire. Between 1986 and 2002, 106 men had heart attacks. This included eight of the 1,282 who drank between 15 and 29.9 grams of alcohol per day (the equivalent of two drinks), nine of the 714 who drank 30 grams or more per day (more than two drinks), 34 of the 2,252 who drank .

1 to 4.9 grams per day and 28 of the 1,889 who did not drink at all. Their final analysis showed that among the subjects who were able to maintain all four healthy behaviours for at least a portion of the follow-up time, those who consumed alcohol in moderation had a 40 to 60 percent lower risk of heart attack than either the non-drinkers or the very light drinkers. "Based on these numbers, we estimate that approximately 25 percent of the heart attacks that occurred among these healthy individuals might be attributed to abstention [or extremely light drinking]," explains Mukamal.

Source: Beth Israel Deaconess Medical Center

Benefits of EDTA Chelation Therapy in Arteriosklerosis

Chelation


more discussion: Forum
· Addiction Forum · Ask the Doctors Forum · Ayurveda Forum · Ayurvedic & Thai Herbs Forum · Colon Cleansing Forum · Dental Forum · Diabetes Forum · Diet Forum · General Cleansing Forum · Hepatitis A, B. C Forum · Integrated Medicine Forum · Live Blood Analysis Forum · Ozone-Oxygen-Forum · pH - Alkaline - Acidity Forum · Weight Loss Forum

Detoxamin CaEDTA Suppositories to Treat Elevated Blood Lead Levels in Children

Detoxamin CaEDTA Suppositories to Treat Elevated Blood Lead Levels in Children
Ted Rozema, MD

Summary: The test results clearly demonstrate the high level of effectiveness of removing lead from the human body with Calcium disodium EDTA rectal suppositories. The effect of lead poisoning on high percentages of the pediatric population is cause for concern.

Lead poisoning is one of the most common and preventable pediatric health problems today. Currently, the primary form of medical intervention consists of expensive and painful CaEDTA intramuscular injection.

The availability of an easily administered effective medical treatment is an important component in controlling the worldwide lead poisoning epidemic.

Introduction: Childhood lead poisoning is one of the most common pediatric health problems in the world today, and it is entirely preventable and reversible.

Enough is now known about the sources and pathways of lead exposure, about ways of preventing this exposure, and about ways of reducing the lead content of the body to begin the efforts to eradicate this disease permanently.

The persistence of lead poisoning, in light of all that is known, presents a singular and direct challenge to public health authorities, clinicians, regulatory agencies, and society. Lead is ubiquitous in the human environment as a result of industrialization. It has no known physiologic value.

Children are particularly susceptible to lead's toxic effects. Lead poisoning, for the most part, is silent: most poisoned children have no symptoms.

The vast majority of cases, therefore, go undiagnosed and untreated. Lead poisoning is widespread. It is not solely a problem of inner city or minority children. No socioeconomic group, geographic area, or racial or ethnic population is spared.

Previous lead statements issued by the Center for Disease Control (CDC) have acknowledged the adverse effects of lead at lower and lower levels. In the most recent previous CDC lead statement, published in 1985, the threshold for action was set at a blood lead level of 25 mcg/dL, although it was acknowledged that adverse effects occur below that level.

In the past several years, however, the scientific evidence showing that some adverse effects occur below levels at least as low as 10 mcg/dL in children has become so overwhelming and compelling that it must be a major force in determining how we approach childhood lead exposure.

It is not possible to select a single number to define lead poisoning. Epidemiological studies have identified harmful effects of lead in children at blood lead levels at least as low as 10 mcg/dL. Some studies have suggested harmful effects at even lower levels, but the body of information accumulated so far is not adequate for effects below about 10 mcg/dL to be evaluated definitively. As yet, no threshold has been identified for the harmful effects of lead.

Because 10 mcg/dL is the lower level of range at which effects are now identified, primary prevention activities are typically directed at reducing children's blood lead levels below 10 mcg/dL or 14 mcg/dL. While the overall goal should be to reduce children's blood lead levels below 10 mcg/dL, there are entrenched reasons for not attempting to do interventions directed at individual children to lower blood lead levels of 10-14 mcg/dL. First, practical medical interventions for children with blood lead levels in this range have previously been unavailable.

Second, the sheer numbers of children in this range would preclude effective case management in established intravenous therapy. Clearly, a simply and effective therapy such as suppository is needed. The single, all-purpose definition of childhood lead poisoning has been replaced with a multi-tiered approach, described in the following table:
CLASS
Blood leadconcentration (mcg/dL)

COMMENT
I 10 A child in Class I is not considered to be lead poisoned. IIA 10-14 Many children (or a large proportion of children) with bloodlead levels in this range should trigger community wide childhood lead poisoning prevention activities.

Children in this range may need to be rescreened more frequently. A decrease in blood lead level would be beneficial. IIB 15-19 Child should receive nutritional and educational interventionsand more frequent screening. If the blood lead level persists inthis range, environmental investigation and intervention should be done.

Non-invasive medical intervention should be done. III 20-44 Environmental evaluation, remediation and a medical examination should take place. Such a child needs pharmacological treatment of lead poisoning. IV 45-69 A child in Class IV will need both medical and environmentalinterventions, including even I.M. chelation therapy. V 69>

A child with Class V lead poisoning is a medical emergency. Medical and environmental managment must begin immediately.

Background: Lead is a poison that affects virtually every system in the body. The risks of lead exposure are not based on theoretical calculations.

They are well known from studies of children themselves and are not extrapolated from data on laboratory animals or high-dose occupational exposure.Since 1970, our understanding of childhood lead poisoning has changed substantially. As investigators have used more sensitive measures and better study designs, the generally recognized level for lead toxicity has progressively shifted downward.

Before the mid-1960's, a level above 60 mcg/dL was considered toxic (Chisholm and Harrison, 1956). By 1978, the defined level of toxicity had declined 50% to 30 mcg/dL.Lower blood lead levels cause adverse effects on the central nervous system, kidney and hematopoietic system. Blood lead levels as low as 10 mcg/dL, which do not cause distinctive symptoms, are associated with decreased intelligence and impaired neurobehavioral development (Davis and Svendsgaard, 1987; Mushak et al, 1989).

The concern about adverse effects on central nervous system functioning at blood lead levels as low as 10 mcg/dL is based on a large number of rigorous epidemiological and experimental studies. Several well-designed and carefully conducted cross-sectional and retrospective cohort studies in many different countries have been conducted (Lansdown et al., 1986; Fulton et al., 1987; Fergusson et al., 1988; Silva et al., 1988; Bergomi et al., 1989; Hansen et al., 1989; Hatzakis et al., 1989; Winneke et al., 1990; Lyngbye et al., 1990; Needleman et al., 1990; Yule et al., 1981; Hawk et al., 1986; Schroeder et al., 1985) Some inconsistencies can be found in the results of these studies, but the weight of the evidence clearly supports the hypothesis that decrements in children's cognition are evident at blood lead levels well below 25 mcg/dL.

No threshold for the lead-IQ relationship is discernable from these data. Recent evaluation of 24 major cross-sectional studies provides strong support for the hypothesis that children's IQ scores are inversely related to lead burden (Needleman and Gatsonis, 1990).According to the Natural Resources Defense Council, blood lead levels as low as 10 mcg/dL, which do not cause distinctive symptoms, are associated with reading and learning disabilities, reduced attention span and behavioral problems.

The ramifications of the proliferation of lead pollution from industrialization combined with the devastating effects of health are sobering. A simple and effective therapy, such as EDTA chelation via suppository, is urgently needed.Methods: A cluster of previously untreated children with high blood lead levels was desired for the purpose of testing the efficacy of Calcium disodium EDTA rectal suppositories to remove toxic metals from the human body. 1.) Determinization of study area: Friends of Lead Free Children, a non-profit organization connected to Columbia University and Fordham University, assisted in the search. A residential neighborhood in Haina, Dominican Republic as selected.

The residential neighborhood was located adjacent to a battery recycling plant. All preliminary testing indicated 100% of residents as markedly toxic with lead.2.) The selection of subjects into the study: Children who had been identified with blood lead levels over 10 mcg/dL were determined in a twenty four (24) hour urine collection by Ion Coupled Plasma Emission Spectroscopy.

Hg. Analysis was determined by cold vapour mercury analysis. 3.) Individual treatment of lead overload: Cautious removal of lead from body depots was achieved through the use of Calcium disodium EDTA rectal suppositories . The use of suppositories provided for the prevention of local corrosive action of toxic metals on mucous membranes.4.) Compensation: Compensation was not paid to subjects; however, no charges were incurred by participants for the drug and laboratory testing.5.) Safety: By determining the concentration of heavy metals in the urine following provocative stimulation, the therapy with EDTA was scientifically determined, providing a safe treatment program.

The study simultaneously provided diagnostic information regarding heavy metal burden as well as a defined treatment protocol for lead toxicity in a pediatric population. EDTA is a substance with low systemic and local toxicity and is generally well tolerated. The drug, per se, has been classified GRAS by the FDA, no cases of anaphylaxis have been reported through the oral administration of EDTA or through its use as a food additive.6.)

Alternative therapies: Alternative therapies were available for the treatment of metal intoxications, including (R,S)-2,3-dimercapto propane-1-sulfonic acid (DMPS) as well as its close standing analog DMSA. A significant advantage of using EDTA suppositories in a pediatric population include:—a) Cooperative binding constant for lead.—b) The suppository route of administration at bedtime was (is) an— easy and acceptable delivery system.—c)

The antioxidant/free radical quenching role of EDTA made it— superior over the other agents available due to the fact that— neurological dysfunction was (is) recognized as a result of free— radical mediated damage.—d) EDTA was already approved for oral administration by the FDA — and is on the GRAS list.—e) EDTA is an ANTIDOTE to counteract the TOXIC action of — lead from the environment.7.) Medical care: Medical care was provided by Universidad de Autonomia de Santa Domingo. In the event of a medical emergency connected with the study, subjects were to contact the appropriate center, but this was never necessary. In addition, all participants could receive product and clinical information by calling: Ted Rozema, M.D., and principal investigator.8.) Data coordination: Data was coordinated and maintained by the principal investigator, all data was statistically analyzed. Information was made available to all appropriate authorities, including IRB of the GLCCM and the FDA.

9.) Clinical laboratory: Clinical laboratory facilities and medical support was provided by AmScot Medical Laboratories, Inc. To ensure the safety and integrity of the study, the following analyses were assessed: — a) Baseline: — Smac 18 with CBC - manual differential Blood lead determination — Urine (24-hour collection) —heavy metals to include: Pb, Cd, Hg, As, Ni, Al — B2 - micro globulin (serum) Anti - TPO Total Ca/Ca2+ Mg/Mg2+ Pt/APTT PTH — b) Provocative EDTA challenge: — Blood lead determination — Urine (9-hour) - heavy metals - Pb, Cd, Hg, As, Ni, Al — B2 - micro globulin (serum) Total Ca/Ca2+ Mg/Mg2+ Pt/APTT PTH —c) Mid-study laboratory evaluation: — Blood lead determination — CBC - manual differential Urine (9-hour) - heavy metals - Pb, Cd, Hg, As, Ni, Al — B2 - micro globulin (serum) — Total Ca/Ca2+ Mg/Mg2+ — Pt/APTT PTH —d) Post study (6 weeks): — Blood lead determination — SMAC 18 with CBC - manual differential — Urine (9-hour) - heavy metals - Pb, Cd, Hg, As, Ni, Al — B2 - micro globulin (serum) — Total Ca/Ca2+ Mg/Mg2+ — Anti-TPO — PTH

Research Protocol: A study to determine the efficacy of Calcium disodium EDTA used as a rectal suppository in removing toxic metals from the human body. Subjects: children with proven lead toxicity (blood lead levels >10mcg/dL). Study design: 1.) Enrollment. 2.) Blood lead levels drawn to enter into study with simultaneous determination of urine lead excretion (total urine minerals - if possible with parental assistance). 3.) Treatment phase. 4.) Placement of a rectal suppository containing 2 grams of Calcium Disodium EDTA nightly for 10 days, then 10 days without EDTA, then placement of the EDTA suppository for 10 days, continue this program for two courses of treatment. 5.) Laboratory determinations:

PRE
AFTER 10 DAYS
AFTER 10 DAYS
AFTER 10 DAYS
BLOOD
XX — Supp
XX — No supp
XX — Supp
XX
URINE
XX — Supp
XX — No supp
XX — Supp
XX

Purpose is to demonstrate gradual reduction of both blood and urine lead levels over time with a simple and cost-effective method. It was anticipated that methods to reduce lead intake would be in place during and after this study. Unfortunately, no environmental mitigation was ever enacted.Specimen Collection Regimen: Pre-study: 1.) Collection of 3 to 5 ml of whole blood in heparinized, lead-free curettes. 2.) Collection of 9 hours of urine.

This was measured from the time the child went to bed until 9 hours later. It was anticipated that the children were not getting up at night to urinate and mother would need to watch to catch the first morning specimen then determine when is the 9 hour point and collect the additional urine to make the complete collectionThis provided a base line for both blood levels and excretion on a daily basis.

Just before the first suppository: 1.) Collection of 1 to 5 ml of whole blood in heparinized, lead-free curettes. 2.) Insertion of the first suppository in the child's rectum, high as possible, just before the child goes to sleep, preferable with the child already in the bed.

The morning after the first suppository: 1.) Collection of 9 hours of urine. This was measured from the time the child went to bed until 9 hours later. It was anticipated that the children were not getting up at night to urinate and mother would need to watch to catch the first morning specimen then determine when is the 9 hour point and collect the additional urine to make the complete collection. The morning before the 10th suppository: 1.) Collection of 3 to 5 ml of whole blood in heparinized, lead-free curettes. The morning after the 10th suppository: 1.) Collection of 9 hours of urine. This was measured from the time the child went to bed until 9 hours later. It was anticipated that the children were not getting up at night to urinate and mother would need to watch to catch the first morning specimen then determine when is the 9 hour point and collect the additional urine to make the complete collection.

The morning of the 19th day: This is the last day without a suppository before the next ten days of suppository administration. 1.) Collection of 3 to 5 ml of whole blood in heparinized, lead-free curettes. 2.) Collection of 9 hours of urine. This was measured from the time the child went to bed until 9 hours later. It was anticipated that the children were not getting up at night to urinate and mother would need to watch to catch the first morning specimen then determine when is the 9 hour point and collect the additional urine to make the complete collection.This gave us a determination of equilibration after no treatment for 10 days.The morning of the 30th day: 1.) Collection of 3 to 5 ml of whole blood in heparinized, lead-free curettes.

The morning after the 30th suppository: 1.) Collection of 9 hours of urine. This was measured from the time the child went to bed until 9 hours later. It was anticipated that the children were not getting up at night to urinate and mother would need to watch to catch the first morning specimen then determine when is the 9 hour point and collect the additional urine to make the complete collection. All specimens were taken to the laboratory of Dr. Conrado Depratt at the Instituto De Quimica of the Universidad Autonoma de Santo Domingo.Results: Average 20 children test data:
BLOOD LEAD LEVELS


Pre-study
66.64
mcd/gL
After 10 days of suppositories
39.09
mcd/gL
After 10 days without suppositories
61.45
mcd/gL
After 10 more days on suppositories
83.67
mcd/gL

URINE LEAD EXCRETION LEVELS


Pre-study
004.23
mcd/gL
After 1st suppository
325.55
mcd/gL
After 10 days of suppositories
061.445
mcd/gL
After 10 days without suppositories
009.04
mcd/gL
After 10 more days on suppositories
022.71
mcd/gL

The data clearly demonstrates that Detoxamin , (EDTA delivered in rectal suppository form), effectively removes lead from children with lead poisoning. The continued high excretion level, after 10 days without Detoxamin is of special interest. Also of special interest is the rebound effect in the blood lead levels. It's degree reflecting the high amount of stored lead in the tissue and bones and the attendant mobilization effect.

Each time the blood lead level was diminished, additional lead was mobilized from the tissues and bones. It was anticipated that methods to reduced lead intake would be in place during and after this study. Unfortunately, no environmental mitigation was ever enacted. Ideally, environmental intervention would have been enforced and the Detoxamin Calcium disodium EDTA rectal suppository therapy would have continued for a 6-month duration. This circumstance was not possible.

more discussion: Forum
· Addiction Forum · Ask the Doctors Forum · Ayurveda Forum · Ayurvedic & Thai Herbs Forum · Colon Cleansing Forum · Dental Forum · Diabetes Forum · Diet Forum · General Cleansing Forum · Hepatitis A, B. C Forum · Integrated Medicine Forum · Live Blood Analysis Forum · Ozone-Oxygen-Forum · pH - Alkaline - Acidity Forum · Weight Loss Forum

Chemical & Heavy Metal Cleanse Starter Kit $149.85 [ learn more ] The Chemical & Heavy Metal Starter Kit was designed by Dr. Group for individuals that are new to the cleansing process, or are simply looking for an easy-to-perform, cost effective cleanse program. The Heavy Metal Starter Kit is comprised of LIFE Detox Foot Patches™, NDF Plus™, and Quantum Zeolite™.

An End to Prostate Problems?

Breakthrough Detoxification Research Now Being Conducted

California, August 30, 2006. Prostate conditions such as prostatitis, enlarged prostate and prostate cancer are affecting men worldwide. In fact, more than 50% of all men 50 and over suffer from an enlarged prostate (Benign Prostate Hyperplasia or BPH).

The problem gets worse as men age. That’s just one possible prostate condition. Another widespread affliction is prostatitis. It affects younger as well as older men. This week, World Health Products received full Investigational Review Board (IRB) approval to conduct clinical trial on an innovative detoxifying product, Detoxamin®, in conjunction with the antibiotic, tetracycline. Pre-study trials indicate that this combination therapy will reduce or eliminate prostate problems.

The study is slated to begin September 9, 2006 at the Tustin Longevity Center in Tustin, California under the direction of Rita Ellithorpe, MD, a specialist in integrative medicine.

A recent discovery has revealed a minute life form, much smaller than the smallest bacteria. It’s called nanobacteria. Many medical scientists believe these culprits cause hardening of the arteries, kidney stones and other degenerative conditions. These ultra microbes are thought to encase themselves in a shell of calcium.

Researchers involved in this current study have uncovered convincing evidence pointing to nanobacteria forming calcifications or stones on the prostate. These continually growing stones are thought to cause pressure on the prostate giving rise to prostatitis and BPH. Studies suggest that calcium biofilm surrounding the nanobacteria can removed by an amino acid, EDTA, contained in a product called Detoxamin.

The nanobacteria are exposed and then destroyed by tetracycline. This one-two approach of killing the nanobacteria with tetracycline and dissolving the calcium deposits with Detoxamin is the foundation for conducting this study. There is evidence that EDTA also has beneficial results in diminishing hardening of the arteries, atherosclosis. Detoxamin also chelates or binds poisonous heavy metals within deep tissues and enables the body to easily eliminate the toxins through urine and feces. “Our clinical trial will determine if prostate calcifications will either reduce in size or be eliminated altogether.

Furthermore, we will also find out if symptoms decrease or disappear,” says Larry Clapp, PhD, co-investigator and author of Prostate Health in 90 Days.
Toxic heavy metals have been implicated in many diseases of aging from Alzheimer’s, to cardiovascular disease. “I have over 500 patients with a variety of conditions in my practice that I placed on Detoxamin; the reason, because mostly everyone I have tested has a variety of heavy metal build up in their bodies.

Detoxamin is a safe, effective and convenient way to remove these menacing toxins. Therefore, we eliminate the causative agents so that other therapies can work in combination and repair the damage heavy metals cause to cells, tissues and organs,” as stated by Dr. Ellithorpe, the Principle Investigator of the study. This new clinical study supports the use of combination therapy to curtail or eliminate the growing prostate problems.

more information at: Chelation

more discussion: Forum
· Addiction Forum · Ask the Doctors Forum · Ayurveda Forum · Ayurvedic & Thai Herbs Forum · Colon Cleansing Forum · Dental Forum · Diabetes Forum · Diet Forum · General Cleansing Forum · Hepatitis A, B. C Forum · Integrated Medicine Forum · Live Blood Analysis Forum · Ozone-Oxygen-Forum · pH - Alkaline - Acidity Forum · Weight Loss Forum

Abnormal Protein Linked to 2 Neurological Diseases

(HealthDay News) -- Researchers have identified the abnormal protein common to two devastating neurological diseases -- Lou Gehrig's disease, which causes death by paralysis, and frontotemporal dementia, which starts with bizarre behavior and has a destructive effect on mental function comparable to Alzheimer's disease.

The protein is prosaically designated TDP-43, according to a report in the Oct. 6 issue of Science led by researchers at the University of Pennsylvania School of Medicine. When it folds abnormally, the protein should be quietly removed from the brain. But in some people, the removal system doesn't work, and the protein accumulates inside brain cells. The damage done depends on where the accumulation occurs.

"This provides a beginning of an area of investigation with the goal of trying to turn it into something useful, first as a biomarker and eventually as a target of therapy," said study leader Virginia Lee, director of the university's Center for Neurodegenerative Disease Research.

It has long been thought that the two conditions are somehow related, Lee said. The TDP-43 protein provides the common thread. When its abnormal form accumulates in cells of the frontal and temporal lobes -- the brain areas that control judgment and comportment -- the result is frontotemporal dementia (FTD). When the accumulation is in the spinal cord cells, which control movement, the result is Lou Gehrig's disease, whose formal name is amyotrophic lateral sclerosis, she said.

The incidence of Lou Gehrig's disease is one in 100,000 Americans, Lee said. The incidence of FTD is unknown because it usually is treated as a psychiatric disorder, but it is believed to be the second most common form of dementia, behind Alzheimer's disease.

The researchers used an immunological approach to isolate the protein, Lee said. Their knowledge of other abnormal proteins in neurological diseases, such as beta amyloid in Alzheimer's, made them believe it had a high molecular weight and was highly insoluble.

Working with brain tissue from people who had FTD, the researchers got rid of low-molecular-weight, soluble proteins. They injected what was left into mice, whose immune systems generated antibodies against the material. Work with more than 50,000 tissue samples eventually pointed to TDP-43, a finding confirmed with the use of commercially available antibodies against the protein.

Research yet to be done will focus on why the protein becomes abnormal in the first place and why the body's disposal system doesn't work properly, Lee said.

Stephen Snyder is a program director in the Neuroscience and Neuropsychology of Aging Program at the National Institute on Aging, which funded the new work. "This paper shows a signature protein," he said. "This is exactly the kind of finding that moves us ahead quickly."
But "quickly" has a distinct meaning in the study of neurological diseases, Snyder said. It has been a quarter century since the role of beta amyloid in Alzheimer's disease was discovered, yet work to develop treatments for the disorder is still under way, he said.

"The neurodegenerative-disease nut cracks open grudgingly," Snyder said. "But all that we have learned with Alzheimer's disease will come into play here. The finding of this particular protein in lesions of these different diseases, that has to count for something. It gives us a mechanism involved in these devastating diseases. How it is involved is an interesting thing to look at."

More information
To learn more about dementia, visit the
National Institute of Neurological Disorders and Stroke.

Behavior Therapy Eases Kids' Sleep Woes

(HealthDay News) -- Behavioral therapies can be an effective means of dealing with bedtime problems and nighttime awakenings in children, a new review of the data finds.
The findings are based on a review of 52 studies with a total of 2,500 infants and toddlers, conducted by a task force appointed by the American Academy of Sleep Medicine (AASM).
The findings are published in the October issue of Sleep.
"The results indicate that behavioral therapies produce reliable and durable changes in bedtime problems and night wakings in infants and children," study author Jodi A. Mindell, of St. Joseph's University in Philadelphia, said in a prepared statement.
"Across all studies, 94 percent report that behavioral interventions produced clinically significant improvements in bedtime problems and/or night wakings," she said. "Approximately 82 percent of children benefit from treatment, and the majority maintain these results for three to six months."
Previous research has shown that 20 percent to 30 percent of young children have significant bedtime problems and/or night awakenings, Mindell said.
The AASM offers some advice for parents to help their children sleep better:
Follow a consistent bedtime routine. Set aside 10 to 30 minutes each night to help your child get ready to go to sleep.
Establish a relaxing setting at bedtime.
Interact with your child at bedtime. Don't let the television, computer or video games take your place at that time.
Don't let infants fall asleep while they're being held, rocked, fed a bottle, or while they're nursing.
At bedtime, don't let your child have foods or drinks that contain caffeine. If possible, do not give children any medicines (such as decongestants and cough medicines) that contain stimulants to children at bedtime.
Experts advise that children get the following amount of sleep: infants (3 to 11 months) -- 14 to 15 hours per night; toddlers -- 12 to 14 hours; preschoolers -- 11 to 13 hours; and school-age children -- 10 to 11 hours.
More information
The National Sleep Foundation has more about children and sleep.

Exercise Alone Won't Prevent Childhood Obesity

(HealthDay News) -- Physically active preschoolers are on to a good thing, but exercise alone won't keep obesity at bay as they get older, British researchers report.

Instead, a combination of exercise and other lifestyle changes -- especially improved diets -- may be the only solution to the childhood obesity epidemic, experts say.

"Promotion of physically active play per se may not be sufficient to have an impact on the weight status of young children," said lead researcher Dr. John J. Reilly, a professor of pediatric energy metabolism at the University of Glasgow, Scotland.

His team published its finding in the Oct. 5 online issue of the British Medical Journal.
The researchers had already shown in earlier work that Scottish preschoolers have surprisingly inactive lifestyles. They typically get less than 30 minutes of moderate to vigorous physical activity each day, in contrast to the recommended 60 minutes a day.

In their study, Reilly's team looked at whether exercise could reduce the weight of 545 preschool children. Some of the children took part in an active play program, which consisted of three 30 minute sessions each week. In addition, parents received guidance on how to increase physical play at home.

The researchers measured the children's weight at six months and then again at one year. They also assessed the youngsters' movement skills, and tracked whether or not the increase in activity reduced sedentary behaviors.

They found that exercise had some health benefits, but weight loss was not among them.
Exercise had little effect on weight, or on the activity behaviors of the children, compared with the children who did not take part in the program. However, for children in the program, additional exercise did help improve their motor and movement skills.

"We know from older studies that improved motor skills, balance, running, skipping, catching a ball, bouncing a ball, is of benefit to children socially and developmentally, and tends to promote engagement in sport, and may help reduce subsequent excess weight gain," Reilly said.

However, most children, even of preschool age, are relatively inactive, Reilly said. "We can't just assume that they are physically active," he said. "[We] must recognize that we need to change the environment at preschool/day care, at home and in the wider environment in ways which help them become more physically active."

There is great pressure on institutions and politicians in Britain to do something about childhood obesity, Reilly added. "While this is fine, it is possible that we will be doing things that might not have the intended effects. Our study shows the importance of rigorous evaluation of public health interventions before they are rolled out," he said.

One U.S. expert agreed that no single program can attack the obesity epidemic.

"It should come as no great surprise that Reilly and colleagues were unable to demonstrate a significant weight change among nursery school children receiving a physical activity program," said Dr. David L. Katz, director of the Prevention Research Center at Yale University School of Medicine. "The program in no way represented an 'equal and opposite force' to such factors as fast food, junk food, the temptations of technology, and suburban sprawl that conspire to make us fat."

The message here is not that the program failed, Katz said, but that "we need to do more than fix one thing at a time."

"We need to improve dietary choices and increase physical activity, in school and at home, every day. We need programs that engage families in a shared commitment to healthful practices, and that reach families via schools, work sites, clinics and community portals such as supermarkets, movie theatres and shopping malls," Katz said. "No one program in isolation can, or should be expected to, bear that burden alone."

More information
There's more on kids and exercise at the American Heart Association.

Detoxamin EDTA Chelation Therapy Suppositories are a new patented method of Ca-EDTA chelation therapy medically equivalent to I.V. chelation therapy.

Detoxamin EDTA Chelation Therapy Suppositories are a new patented method of Ca-EDTA chelation therapy medically equivalent to I.V. chelation therapy.

The difference is that Detoxamin introduces a smaller dosage of Calcium Disodium EDTA on a nightly basis.

By applying the highly efficacious Detoxamin suppository containing EDTA, you remove toxic metal from cells all over the body.

The self-administration is performed rectally before retiring so that as you sleep you are taking chelation therapy with EDTA. There's no need for intravenous infusions or quantities of nutritional supplements.

What is EDTA chelation therapy and what is it used for?Chelation (pronounced key-lay-shun) is the process by which a metal or mineral (such as lead, mercury, iron, arsenic, aluminum, etc.) is bonded to another substance-in this case an amino acid called EDTA, Ethylene-Diamine-Tetra-Acetic acid. It is a natural process, basic to life itself. During EDTA chelation therapy, the EDTA infusion bonds with unwanted metals in the body and quickly carries them away in the urine.

Chelation therapy is a safe, effective alternative to drugs and surgeries and is used to treat many illnesses now known to be linked to the presence of toxic heavy metals. Illnesses such as heart disease, strokes, diabetes, circulatory disorders, neuropathies, Alzheimer's disease, atherosclerosis, and adverse reactions to many environmental pollutants. Traditional chelation therapy uses an intravenous drip, and is administered in the outpatient setting.

The number of treatments vary based on each person's individual condition and/or goals of treatment. The average therapy is given one to three times a week for twenty to thirty treatments.How long has EDTA chelation therapy been in use? Why don't more people use it?EDTA chelation therapy for the detoxification for heavy metals has been in continuous use since the 1940s when it was introduced specifically for the treatment of lead poisoning. It was very quickly observed that as the metals were eliminated, not only did the signs and symptoms of lead poisoning abate, but problems related to the circulatory system like heart attacks, angina, strokes, and peripheral vascular disease also improved.

For the past 50 years, well over one million people have received the intravenous form of EDTA chelation. As beneficial and life saving as this therapy has become, it is very expensive and very time-consuming, making it out of reach for most people.Why is Ca-EDTA, Calcium Disodium EDTA, so much better than other types of chelation therapy?According to Dr. Bruce Halstead, "The chemistry of all chelators is such that a change of pH can dramatically effect the process of chemical binding needed to chelate a mineral or metal. When you use a less effective chelator, such as Magnesium EDTA, you lose all chelating ability of the two most essential heavy metals: lead and mercury. Magnesium di-Potassium EDTA has a dramatically lower chelating effectiveness than Calcium EDTA because both magnesium and potassium dramatically decrease the pH in the blood environment to which it is introduced. Any factor decreasing pH renders EDTA less effective.

Once the pH is lowered more than 7.38, it's no longer chemically conducive to any bonding or chelating." (Dr. Halstead is well known as the 'Father of Chelation Therapy'.)

Dr. Morton Walker Speaks on Detoxamin - Toxic Metals Induce Degenerative Diseases; Rectal Chelation Therapy Overcomes Them.

Environmentalists warn us repeatedly that we live on a poisoned planet. Toxins from mercury, lead, aluminum, cadmium, iron, nickel, and about 20 more metallic minerals permeate the Earth's milieu. Heavy and light metals poison us by combining to create deleterious signs and symptoms often referred to collectively as Toxic Metal Syndrome.

This syndrome, an indicator of serious systemic pathology, results in degenerative diseases which affect no less than 92% of the populations of Western industrialized nations, in particular, those people living in apartment high-rises and other polluted city dwellings. What happens to them? These poisoned people eventually come down with manifestations of degenerative illnesses such as heart and/or blood vessel deteriorations; pancreatitis; gout, rheumatoid arthritis or osteoarthritis; the syndromes of yeast, chronic fatigue, and/or irritable bowel; Alzheimer's disease, multiple sclerosis, parkinsonism, and many more which may be deadly-cancer for instance.

Although a poisoned person's bones remain toxic for life, excellent self-treatment exists to reduce or reverse most symptoms of illness in other body parts. First, get tested for the extent of toxicity, then neutralize metallic poisoning with a chelating agent such as Detoxamin. By applying the highly efficacious Detoxamin suppository containing EDTA, you remove toxic metal from cells all over the body. The self-administration is performed rectally before retiring so that as you sleep you are taking chelation therapy with EDTA. There's no need for intravenous infusions or quantities of nutritional supplements.Rectal chelation therapy does the job of detoxifying in a low-cost, convenient manner; it's an effective way to effuse EDTA through the bowel's walls and into your blood stream to clean toxic metals from all body cells.

Do I need Ca-EDTA chelation therapy?
We find ourselves existing in a far more toxic and hostile environment than our bodies were designed to handle. Experts have shown that almost every health problem-from learning disorders to cancer and heart disease-is aggravated by the approximate 1,000% increase in lead levels in our bones. In 1999, it was reliably reported that hearts with some form of disease have 20,000 times more toxic heavy metals than healthy hearts."Human exposure to heavy metals has risen dramatically in the last 50 years as a result of an exponential increase in the use of heavy metals in industrial processes and products." says Maile Pouls, Ph.D (Townsend Letter for Doctors and Patients, July 1999).A recently concluded "Body Burden" study by New York's Mt. Sinai Hospital and the Environmental Working Group was reviewed by University of Oregon Professor Joseph Thornton: "It shows the universality of chemical contamination of people's bodies," Thornton said.

All the studies "confirm the general message that everybody in our society has these chemicals building up. Some people have it worse than others, but everyone has it. No one is clean anymore." (From Being Careful Can't Keep Chemicals Out of Your Body, Miami Herald, February 1, 2003.)Today we know that about one out of every 2.5 Americans will get cancer. Ninety eight percent of cancer is caused by toxic chemicals. When 50% of all men and 33% of all women living now will die of cancer, something is terribly wrong. (Mortality from cancer was reduced by 90% during an 18-year study of 59 patients treated with Calcium-EDTA. This and over 40 other studies prove the efficacy of Ca-EDTA, Calcium Disodium EDTA chelation therapy and Detoxamin. We will all function better and live longer if we lower the overall burden of toxic metals within ourselves. If you eat or breathe, you will probably benefit greatly from chelation therapy.

Is Detoxamin safe for children?
Yes. In fact, Detoxamin case studies were conducted on lead poisoning in children. The study showed no significant increase in BUN or creatinine levels even in very young children. Due to our lower dosage and time release formulation, no renal toxicity was encountered.BEHAVIORAL, STRUCTURAL, FUNCTIONAL ABNORMALITIES ASSOCIATED WITH VARIOUS HEAVY METAL TOXINS.Reference: Published in the August issue of Alternative & Complimentary Therapies (a magazine for doctors) and Published in Townsend Letter for Doctor's and PatientsPsychiatric Disturbances:
Social Deficits, Social withdrawal

Mercury
Repetitive, perseverative, stereotyped behaviors; OCD-typical behaviors
Mercury
Depression, mood swings, flat affect; impaired facial recognition

Arsenic, Copper, Lead, Mercury
Schizoid tendencies; hallucinations; delirium
Mercury
Irritability, aggressive behaviors, temper tantrums
Lead, MercurySuicidal Behaviors
Copper, MercurySleep difficulties / disturbancesLead, Mercury, Thallium
Chronic fatigue (CFS); weakness, malaise
Aluminum, Arsenic, Cadmium, Copper, Lead, Mercury, Thallium
Anorexia; symptoms reflecting eating disorders, loss of appetite/weight
Arsenic, Lead, Mercury
Anxiety; nervous tendencies

Thallium
Attentional problems (ADHD), lacks eye contact, impaired visual fixation
Lead, Mercury

Speech and Language Deficits: Speech disorders
A luminum, MercuryLoss of speech, developmental problems with language Mercury
Speech comprehension deficits

Mercury
Dysarthria; articulation problems; slurred speech, unintelligible speech
Mercury
Cognitive Impairments:Mental retardation, borderline intelligence

Arsenic, Lead, Mercury
Uneven performance on IQ scores, low IQ scores
Copper, LeadPoor concentration, attention deficits (ADHD, response inhibition

Aluminum, Lead
Poor memory (short term, verbal, and auditory)
Aluminum, Lead

Difficulties understanding abstract ideas; difficulty carrying out complex commands

X metals
Dementia; pre-senile and senile dementia
Aluminum
Stupor

Aluminum, Arsenic

Impaired reaction time; lower performance on timed tests

Lead
Sensory Abnormalities:
Abnormal Sensations in the mouth and extremities
Arsenic
Hearing loss, difficulty hearing
Arsenic, Lead, MercuryAbnormal touch sensations; diminished touch sensations, aversion to touch
Arsenic
Blurred vision; sensitivity to light
Arsenic, Mercury
Motor Disorders:
Choreiform movements, myoclonal jerks, unusualpostures

Copper, Mercury
Difficulty walking, swallowing, talking
Copper, Mercury

Flapping, circling, rocking, toe walking
Mercury
Problems with intentional movements or imitation
MercuryAbnormal, gait/posture; incoordination, loss of balance; problems sitting, lying, crawling and walking
Mercury

Decreased locomotor activity
Aluminum, Arsenic
Convulsion; seizure
Aluminum, Arsenic, Copper, Lead, Mercury, Thallium

Physiological Impairment, Brain and Central Nervous System:
Neurofibrillary tangles
Aluminum
Neuritis, retrobulbar neuritis; neuropathy
Aluminum, Arsenic, Lead, Thallium
EncephalopathyAluminum, Arsenic, Lead, Thallium
Cerebrovascular diseaseX metals

Alterations in nerve conduction velocity
Lead
Alterations in the spinal cordThalliumAccumulates in CNS structures
Aluminum, MercuryAbnormal EEGs

Arsenic, Lead
Autonomic disturbancesCopper, Lead, Mercury, Thallium

Peripheral Nervous System:Peripheral neuropathyArsenic, Mercury

Alterations in peripheral nerves
Arsenic
Loss of feeling/ numbness in the extremities; paresthesia

Arsenic, Mercury, Thallium

Gastrointestinal Tract:
Nausea, vomiting, diarrhea; loss of appetite

Arsenic, Mercury

Abdominal pain, stomach cramps; burning of the throat of the mouth

Arsenic, Copper, Lead, Mercury, Thallium

Esophagitis; gastroenteritis; colitis

Arsenic, Mercury, Thallium Cancers (colon, pancreatic, stomach, or rectal) Arsenic

Renal and Hepatic Impairment:Hepatotoxicity; Liver dysfunction, damageArsenic, Copper, Thallium

Cirrhosis of the liver; hepatitis

Copper

Kidney disease; kidney failureArsenic, Lead, MercuryRenal toxicity; tubular proteinosisArsenic, Copper, LeadKidney Damage, histological alterations

Arsenic, Lead
Cardiovascular System:Blood vessel damage

ArsenicAnemia; decreased red blood cell count

Arsenic, CopperHypertension; increased heart rate (tachycardia)

Arsenic, Copper, Lead, Thallium

Electrocardiac disorders, Peripheral vascular disease; cardiovascular disease, vascular collapse

Arsenic, Lead
Respiratory System:Pulmonary Fibrosis

Aluminum, Arsenic
Pulmonary edema

X metals
Pneumonia, laryngitis, pharyngitis, bronchitis

Aluminum, Arsenic, Mercury
Restrictive airway disorders, asthmatic conditions, pneumoconiosisArsenic, Aluminum

Nasal ulcers, perforation of the nasal septumX metalsImmune System:Increased incidences of asthma, autoimmune-like symptoms, & allergies
X metals

Inhibition of lymphocytes, T-cells, monocytes X metals
Immunosuppression

LeadDecreased white blood cell count
Arsenic, ThalliumReproductive System:Genital abnormalitiesAluminum, ThalliumDisturbances in menstrual cycle; menstrual painsCopper, MercuryBirth defects; premature births; Spontaneous abortionArsenic, Lead, MercuryReproductive dysfunctionArsenic, AluminumOther Physical Disturbances:Hypotonia or hypertonia; decreased muscular strengthX metalRashes, contact dermatitis; eczema, itchy/irritating skinAluminum, Arsenic, Copper, MercuryMuscle pain; headache; acrodynia; colicArsenic, Copper, Lead, ThalliumAlopecia (hair loss)Thallium Reference: Published in the August issue of Alternative & Complimentary Therapies (a magazine for doctors) and Published in Townsend Letter for Doctor's and Patients.

Detoxamin Usage Instructions: Detoxamin EDTA Suppositories are solid, bullet-shaped preparations designed for easy insertion into the anus (back passage). Detoxamin is manufactured in a cocoa-butter base, a time-release agent (fatty acid base), and 750 mg of Calcium-Disodium EDTA. Detoxamin will dissolve at body temperature and will gradually spread over the lining of the lower bowel (rectum), where it is absorbed into the bloodstream. Detoxamin is designed to release 750 mg Calcium Disodium EDTA slowly, over an 80-minute period.

A. Detoxamin Protocol for More Severe Cases:
1. Take one suppository at night, prior to bedtime.
2. Take every night for up to 90 days. This will provide the medical equivalence of 30 IV Chelation treatments.
3. Take proper mineral/trace mineral/vitamin replacement every day.
4. Take all other suplementaion every day.B. Detoxamin Protocol for Less Severe Cases/Anti-Aging/Prevention:
1. Take Detoxamin every OTHER night, prior to bedtime.
2. Take Detoxamin every other night for 180 days (90 suppositories). This will provide the medical equivalence of 30 IV chelation treatments.
3. Take proper mineral/trace mineral/vitamin replacement every day.
4. Take all other supplementation every day.

Detoxamin Protocol AFTER A or B is completed:
Your bones are toxic for life. Lead and other heavy metals are stored in the bones and get re-distributed into the bloodstream. Therefore, it is highly recommended to continue maintenance with Detoxamin, this provides the ultimate in Anti-aging benefits.

1. Take 5 Detoxamin suppositories over a 30-day period. This porvides medically equal to about 2 EDTA IV treatments.
2. Take porper mineral/trace mineral/vitamin replacement every day.

Note: Detoxamin is designed to be taken at night, however some patients and physicians prefer taking a suppository in the morning after evacuation. (Optional)

How to Use Detoxamin:
Insert Detoxamin suppositories at night, prior to bedtime.
Eat early in the evening, about 4 hours prior to bedtime. (Reduces any discomfort).
1. Go to the toilet and empty your bowels if necessary.
2. Wash your hands.
3. Remove the plastic wrapping from Detoxamin.
4. Either squat or lie on your side with one leg bent and the other staight.
5. Gently but firmly push the suppository into the rectum, FLAT end first until past the sphincter muscle. By inserting the flat end first opposed to the pointed end, the suppository will travel higher up in the rectum more easily. If necessarey moisten the suppository with a little water. Push it in far enough so it doesn't slip out.
6. Close your legs and sit or lay still for a few minutes.
7. Wash your hands again.
8. Try not to empty your bowels for at least 80 minutes.
9. It is optional to take Detoxamin in the morning, after evacuation.

STORAGE: Store Detoxamin in a cool dark place, but not in the fridge. If Detoxamin suppository gets warm it may melt, put the fridge for a few minutes, this will return the suppository to its original state so it may be inserted.
Shelf Life: 2 Years
More information’s: here Chelation

Mom's Mental Health Woes Can Pass to Kids

(HealthDay News) -- The children of mothers who have mental health, substance abuse or domestic violence problems a year after delivery are more likely to experience behavioral problems at age 3, a U.S. study finds.

In their three-year study, researchers at Mathematica Policy Research Inc., in Princeton, N.J., followed nearly 2,800 children born in 18 large U.S. cities.

A year after delivery, half the mothers had a condition in at least one of the three categories -- mental health, substance abuse, domestic violence -- and 22 percent of the children had at least one type of behavior problem such as aggression, anxiety-depression, or inattention/hyperactivity. The more problems reported by a mother, the more likely her child was to develop behavior problems by age 3.

The study also found that when mothers reported difficulties in zero, one, two, or three areas, reports of aggression among their children at age 3 increased from 7 percent to 12 percent to 17 percent to 19 percent, respectively; anxiety and depression increased from 9 percent to 14 percent to 16 percent to 27 percent; and inattention/hyperactivity increased from 7 percent to 12 percent to 15 percent to 19 percent.

The authors noted that mothers' mental health problems, substance abuse and domestic violence tend to accompany each other and have cumulative negative effects on children.
However, "there is evidence that mothers appear open to empathic inquiries about how they are doing, and that mothers also understand that their own well-being is related to that of their children," the study authors wrote.

"Whether a clinician is focused primarily on the care of children, adults or pregnant women, there is the potential to help disrupt this intergenerational transmission of poor health," they concluded.

The study appears in the May issue of the Archives of General Psychiatry.
More information
The American Academy of Pediatrics has more about children's behavior.

Ritalin May Keep Mental Distraction at Bay

(HealthDay News) -- Ritalin, a drug widely used to treat attention deficit-hyperactivity disorder (ADHD), appears to work by tweaking the brain so it isn't as easily distracted by stimuli from the outside world, a new study in rats suggests.

Experts caution that the findings aren't definitive and may have nothing to do with how the drug works in children and adults with ADHD. Still, the research could lead to better understanding of both Ritalin and the disorder, said co-author Barry Waterhouse, a professor of neurobiology and anatomy at Drexel University, in Philadelphia.

"It will begin to help us understand how ADHD may work," he said.
People with ADHD often have trouble focusing on tasks, and may be hyperactive and impulsive. However, some skeptics question whether more people are being diagnosed with ADHD than actually have it.

What's also been unclear is just how Ritalin (methylphenidate) and other stimulants successfully treat as many as 80 percent of ADHD patients -- a success rate higher than any other class of psychiatric drugs, said Dr. David W. Goodman, an assistant professor at Johns Hopkins University and director of the Adult Attention Deficit Disorder Center of Maryland.

In fact, it's "counterintuitive" that Ritalin -- a stimulant -- would dampen ADHD symptoms, noted study co-author Waterhouse. That's because the disorder itself manifests as a form of neurological overstimulation.

Researchers suspect that Ritalin somehow affects neurotransmitters, the chemicals that help signals travel through the brain.

In the new research, Waterhouse and colleagues studied the brains of rats who were given Ritalin and then had their whiskers stroked, to stimulate their brains. Their findings appear in the May 30 online edition of the Journal of Neurophysiology.

Ritalin appeared to change the way the rodents' brains reacted to the stimulus by dampening signals that alert rats that something is going on, Waterhouse said. "The signal is being suppressed, and therefore irrelevant signals are not receiving the same level of brain response" as more important signals, he said.

In essence, the drug may allow the rats to not be easily distracted, he said. According to him, this could reflect what happens in mentally healthy humans who take Ritalin: they become better able to concentrate.

However, the rats in the study weren't an ideal match for human patients, because they didn't have a rodent equivalent of ADHD, Goodman said. While some animals have conditions that reflect human mental illnesses, such as depression or anxiety, he said he's not aware of any animal that develops something like ADHD.

So, while the new study is "interesting," Goodman said, "it's a quantum leap to take the findings and say anything about ADHD in humans."

More information:
For more on treating ADHD, head to the American Academy of Pediatrics.

Antipsychotic Drug Prescriptions for Kids Soaring

(HealthDay News) -- The use of antipsychotic drugs prescribed for children has soared six-fold since the early 1990s, a new report finds.

The surge appears to be largely due to doctors who prescribe the drugs to treat mental illnesses -- including behavior disorders and mood disorders -- that don't have a psychotic component. In many cases, the U.S. government frowns on such "off-label" treatment, but it is legal.

The report findings are a cause for concern, because it's not clear how the drugs work in children, said study lead author Dr. Mark Olfson, professor of clinical psychiatry at Columbia University College of Physicians & Surgeons.

"They've been used in ways that haven't been as extensively studied and for which they haven't been approved by the FDA (U.S. Food and Drug Administration)," Olfson said. "Whenever the practice gets out in front of the science, there's reason for concern."

Olfson and his colleagues examined figures from annual federal surveys of doctors about their practices. The study findings appear in the June issue of the journal Archives of General Psychiatry.

Based on the survey results, the researchers estimate that the number of office visits by children 20 and younger that included prescriptions for antipsychotic drugs grew from 201,000 in 1993 to 1.2 million in 2002. About 18 percent of visits to psychiatrists resulted in prescriptions for antipsychotic drugs.

Antipsychotic drugs are designed to treat people with psychotic disorders that give them a warped sense of reality. But the study shows that doctors are using them for other purposes for children, including behavior disorders (38 percent) and mood disorders (32 percent).

In some cases, the drugs aren't federally approved for treatment of those conditions, but doctors can still legally prescribe them for "off-label" uses.

Children with behavior disorders may be threatening or intimidating other children, Olfson said. What's more, the decline of psychiatric hospitalization of children is forcing psychiatrists to treat children with more severe symptoms. "Part of it is, also, that there aren't a lot of other alternatives to help with the management of kids who have serious behavioral problems," he said.

But it remains unclear exactly how antipsychotic drugs affect children, said Dr. William Cooper, associate professor of pediatrics at Vanderbilt Children's Hospital, who's familiar with the study's findings.

"For things like attention-deficit disorder, depression and bipolar disorder, the bottom line is we don't know whether they work for those conditions in children, and we don't know what side effects they have in kids," Cooper said.

Some newer antipsychotic medications seem to cause weight gain, diabetes and heart rhythm irregularities, Cooper said.
Still, when psychiatrists "find themselves faced with a child having out-of-control behavior, they may think there's not a lot of other options," he said.

More information
Visit the American Academy of Child & Adolescent Psychiatry for more on psychiatric medication for children.